NURIX THERAPEUTICS INC shareholders Q3 2023

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 129 filers reported holding NURIX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.

NURIX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,822,883$14,327,8601.60%
DAFNA Capital Management LLC 556,695$4,375,6231.36%
Redmile Group, LLC 2,848,827$22,391,7801.06%
Deep Track Capital, LP 2,997,830$23,562,9440.91%
WestHill Financial Advisors, Inc. 283,333$2,226,9970.65%
Soleus Capital Management, L.P. 814,000$6,398,0400.59%
Affinity Asset Advisors, LLC 250,000$1,965,0000.55%
Boxer Capital, LLC 1,224,892$9,627,6510.51%
AtonRa Partners 24,227$190,4240.40%
WASATCH ADVISORS LP 3,564,616$28,017,8820.18%
Baker Brothers Advisors 3,882,125$30,513,5030.18%
ARK Investment Management 2,593,047$20,381,3490.16%
GSA CAPITAL PARTNERS LLP 195,420$1,5360.13%
GLOBEFLEX CAPITAL L P 140,500$1,104,3300.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 280,760$2,206,7740.12%
Corton Capital Inc. 26,564$208,7930.10%
Candriam S.C.A. 968,110$7,609,3450.05%
Virtus ETF Advisers LLC 9,011$70,8260.04%
Jasper Ridge Partners, L.P. 95,711$752,2880.04%
KENNEDY CAPITAL MANAGEMENT LLC 163,623$1,286,0770.03%
External links

This page lists NURIX THERAPEUTICS INC's shareholders in Q3 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.